首页> 外文期刊>Neurosurgical focus >Incidence of heterotopic ossification after implantation of interspinous process devices
【24h】

Incidence of heterotopic ossification after implantation of interspinous process devices

机译:植入梭菌过程装置后异位骨化发生率

获取原文
           

摘要

Object This study aimed to investigate the incidence rate of heterotopic ossification (HO) after implantation of Coflex interspinous devices. Possible risk factors associated with HO were evaluated. Methods The authors retrospectively analyzed patients who had undergone single-level (L4–5) implantation of a Coflex device for the treatment of lumbar spinal stenosis. Patient data recorded were age, sex, height, weight, body mass index, smoking habits, and surgical time. Heterotopic ossification was identified through lumbar anteroposterior and lateral view radiographs. The authors developed a simple classification for defining HO and compared HO-positive and HO-negative cases to identify possible risk factors. Results Among 32 patients with follow-up times of 24–57 months, HO was detectable in 26 (81.2%). Among these 26 patients, HO was in the lateral space of the spinous process but not in the interspinous space in 8, HO was in the interspinous space but did not bridge the adjacent spinous process in 16, and interspinous fusion occurred at the level of the device in 2. Occurrence of HO was not associated with patient age, sex, height, weight, body mass index, smoking habits, or surgical time. Conclusions A high incidence of HO has been detected after implantation of Coflex devices. Clinicians should be aware of this possible outcome, and more studies should be conducted to clarify the clinical effects of HO.
机译:本研究的目的旨在探讨Coflex Interspordoints植入后异位骨化(HO)的发生率。评估与HO相关的可能危险因素。方法采用作者回顾性地分析了经过单级(L4-5)植入Coflex装置的患者,以治疗腰椎狭窄。记录的患者数据是年龄,性别,身高,体重,体重指数,吸烟习惯和手术时间。通过腰椎剂量和侧视图射线照相鉴定出异位骨化。作者开发了一个简单的分类,用于定义HO,并比较Ho-阳阳和Ho-负病例,以确定可能的危险因素。结果32例随访时间为24-57个月,HO可检测到26例(81.2%)。在这些26名患者中,HO在棘突的横向空间中,但在8中的梭风空间中,HO在梭鼻间隙中,但没有在16中桥接相邻的棘突,并且偶尔融合在2.何发生的设备与患者年龄,性别,身高,体重,体重指数,吸烟习惯或手术时间无关。结论植入CoFlex器件后已经检测到HO的高发病率。临床医生应该了解这一可能结果,并且应进行更多的研究以澄清HO的临床影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号